[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341793-105":59,"doc-detail-341793-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","fdx1-downregulation-activates-mitophagy-and-the-pi3kakt-signaling-pathway-to-promote-hepatocellular-carcinoma-progression","FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression","","Mitochondrial dysfunction and metabolic reprogramming drive hepatocellular carcinoma (HCC) development and progression. Ferredoxin 1 (FDX1) is a mitochondrial protein implicated in tumor cuproptosis, yet its HCC-specific role remains unclear. This study characterizes FDX1 expression and function in HCC, integrating dataset analysis with immunohistochemistry, qRT-PCR, Western blot, metabolomics, and RNA-sequencing. FDX1 deficiency increases ROS, activates mitophagy and PI3K/AKT signaling, promoting proliferation, invasion, and metastasis, while FDX1 elevation suppresses HCC progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fdx1-downregulation-activates-mitophagy-and-the-pi3kakt-signaling-pathway-to-promote-hepatocellular-carcinoma-progression/341793/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fdx1-downregulation-activates-mitophagy-and-the-pi3kakt-signaling-pathway-to-promote-hepatocellular-carcinoma-progression/341793.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does FDX1 expression change in hepatocellular carcinoma?","Question",{"text":112,"@type":113},"FDX1 expression is significantly downregulated in HCC tissues compared with controls. Low FDX1 is also associated with shorter survival and independently predicts prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the main mechanism linking FDX1 to HCC progression?",{"text":117,"@type":113},"FDX1 deficiency elevates reactive oxygen species (ROS), which activates mitophagy and the PI3K/AKT signaling pathway. This activation supports tumor-promoting behaviors in HCC cells.",{"name":119,"@type":110,"acceptedAnswer":120},"Does altering ROS affect the role of FDX1 downregulation?",{"text":121,"@type":113},"Yes. Scavenging ROS attenuates the tumor-promoting effect and the mitophagy induced by FDX1 downregulation, indicating ROS is a key mediator.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341793,1790152997,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Redox Biology 75 (2024) 103302  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \n| FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production\u003Cbr>Bo Suna, b, c , Peng Dinga , Yinghui Song a , Jia Zhou a , Xu Chena , Chuang Penga, c, ** , Sulai Liu a, b, c, *\u003Cbr>a Department of Hepatobiliary Surgery, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, 410005, China b Hunan Engineering Research Center of Digital Hepatobiliary Medicine, Changsha, 410005, China\u003Cbr>c Hunan Key Laboratory for the Prevention and Treatment ofBiliary Tract Diseases, Changsha, 410005, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Hepatocellular carcinoma Ferredoxin 1\u003Cbr>Mitophagy\u003Cbr>Reactive oxygen species PI3K/AKT signaling pathway |  | Background: Mitochondrial dysfunction and metabolic reprogramming can lead to the development and progression of hepatocellular carcinoma (HCC). Ferredoxin 1 (FDX1) is a small mitochondrial protein and recent studies have shown that FDX1 plays an important role in tumor cuproptosis, but its role in HCC is still elusive. In this study, we aim to investigate the expression and novel functions of FDX1 in HCC.\u003Cbr>Methods: FDX1 expression was first analyzed in publicly available datasets and verified by immunohistochemistry, qRT-PCR and Western blot. In vitro and in vivo experiments were applied to explore the functions of FDX1. Non-targeted metabolomics and RNA-sequencing were used to determine molecular mechanism. mRFP-GFP-LC3 lentivirus transfection, Mito-Tracker Red and Lyso-Tracker Green staining, transmission electron microscopy, flow cytometry, JC-1 staining, etc. were used to analyze mitophagy or ROS levels. Hydrodynamic tail vein injection (HTVi) and patient-derived organoid (PDO) models were used to analyze effect of FDX1 overexpression. Results: FDX1 expression is significantly downregulated in HCC tissues. FDX1 downregulation promotes HCC cell proliferation, invasion in vitro and growth, metastasis in vivo. In addition, FDX1 affects metabolism of HCC cells and is associated with autophagy. We then confirmed that FDX1 deficiency increases ROS levels, activates mitophagy and the PI3K/AKT signaling pathway in HCC cells. Interestingly, scavenging ROS attenuates the tumor-promoting role and mitophagy of FDX1 downregulation. The results of HTVi and PDO models both find that FDX1 elevation significantly inhibits HCC progression. Moreover, low FDX1 expression is associated with shorter survival and is an independent risk factor for prognosis in HCC patients.\u003Cbr>Conclusions: Our research had investigated novel functions ofFDX1 in HCC. Downregulation of FDX1 contributes to metabolic reprogramming and leads to ROS-mediated activation of mitophagy and the PI3K/AKT signaling pathway. FDX1 is a potential prognostic biomarker and increasing FDX1 expression may be a potential therapeutic approach to inhibit HCC progression. |\n\n1. Introduction  \nLiver cancer is the most common cause of cancer-related death in China, ranking fourth in terms of incidence and second in terms of mortality among men [1]. Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer and accounts for 75–85% of all cases of liver cancer [2]. HCC is often diagnosed at an advanced stage when curative surgical treatment is no longer an option. Current  \nmolecularly targeted therapies and immunotherapies have shown limited clinical benefit due to drug resistance or recurrence, highlighting the urgent need for a deeper understanding of the molecular mechanisms underlying HCC progression and the identification of novel therapeutic targets to develop more effective treatments.  \nFerredoxin 1 (FDX1) is a sma","cbCailkegIlFGzCk","https://ap.wps.com/l/cbCailkegIlFGzCk","pdf",27961477,16,"English","# Background and Aim\n# Methods\n## Experimental validation and mechanistic assays\n# Results\n## FDX1 downregulation in HCC\n## ROS-mediated mitophagy and PI3K/AKT activation\n## Therapeutic implication from HTVi and PDO models\n# Conclusions","[{\"question\":\"How does FDX1 expression change in hepatocellular carcinoma?\",\"answer\":\"FDX1 expression is significantly downregulated in HCC tissues compared with controls. Low FDX1 is also associated with shorter survival and independently predicts prognosis.\"},{\"question\":\"What is the main mechanism linking FDX1 to HCC progression?\",\"answer\":\"FDX1 deficiency elevates reactive oxygen species (ROS), which activates mitophagy and the PI3K/AKT signaling pathway. This activation supports tumor-promoting behaviors in HCC cells.\"},{\"question\":\"Does altering ROS affect the role of FDX1 downregulation?\",\"answer\":\"Yes. Scavenging ROS attenuates the tumor-promoting effect and the mitophagy induced by FDX1 downregulation, indicating ROS is a key mediator.\"}]","FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression | PDF",1790043848,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3663e095c3e39e103470b7b79d13272f.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef1c368486dc78010366149a90a11a26.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a361001d0e25e34adb7c212132a7a5a.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72a4898c72d4c62cbe5a71de754c1bd7.webp",980,1306]